1. Home
  2. HURA vs CPOP Comparison

HURA vs CPOP Comparison

Compare HURA & CPOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HURA
  • CPOP
  • Stock Information
  • Founded
  • HURA 2009
  • CPOP 2007
  • Country
  • HURA United States
  • CPOP China
  • Employees
  • HURA N/A
  • CPOP N/A
  • Industry
  • HURA
  • CPOP Services-Misc. Amusement & Recreation
  • Sector
  • HURA
  • CPOP Consumer Discretionary
  • Exchange
  • HURA Nasdaq
  • CPOP Nasdaq
  • Market Cap
  • HURA 122.0M
  • CPOP 98.5M
  • IPO Year
  • HURA N/A
  • CPOP 2021
  • Fundamental
  • Price
  • HURA $3.06
  • CPOP $0.85
  • Analyst Decision
  • HURA Strong Buy
  • CPOP
  • Analyst Count
  • HURA 2
  • CPOP 0
  • Target Price
  • HURA $11.50
  • CPOP N/A
  • AVG Volume (30 Days)
  • HURA 773.7K
  • CPOP 3.1M
  • Earning Date
  • HURA 08-14-2025
  • CPOP 08-26-2025
  • Dividend Yield
  • HURA N/A
  • CPOP N/A
  • EPS Growth
  • HURA N/A
  • CPOP N/A
  • EPS
  • HURA N/A
  • CPOP N/A
  • Revenue
  • HURA N/A
  • CPOP $65,186,721.00
  • Revenue This Year
  • HURA N/A
  • CPOP N/A
  • Revenue Next Year
  • HURA N/A
  • CPOP N/A
  • P/E Ratio
  • HURA N/A
  • CPOP N/A
  • Revenue Growth
  • HURA N/A
  • CPOP 108.29
  • 52 Week Low
  • HURA $1.80
  • CPOP $0.46
  • 52 Week High
  • HURA $8.63
  • CPOP $2.47
  • Technical
  • Relative Strength Index (RSI)
  • HURA N/A
  • CPOP 49.21
  • Support Level
  • HURA N/A
  • CPOP $0.81
  • Resistance Level
  • HURA N/A
  • CPOP $0.93
  • Average True Range (ATR)
  • HURA 0.00
  • CPOP 0.29
  • MACD
  • HURA 0.00
  • CPOP -0.04
  • Stochastic Oscillator
  • HURA 0.00
  • CPOP 10.67

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

About CPOP Pop Culture Group Co. Ltd

Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.

Share on Social Networks: